MediBrief Internal Medicine is a free, digital medical magazine designed specifically for healthcare providers. Published monthly, it delivers concise medical updates through summarized content from top conferences and credible journals in 2-minute videos.
01
GLP-1 AGONISTS: TRANSFORMING DIABETES AND OBESITY CARE
Why are GLP-1 Receptor Agonists a Game-changer for Type 2 Diabetes?
Are GLP-1 Receptor Agonists a Breakthrough for Weight Loss or a Muscle Mass Disaster?
What’s New in Obesity Management?
05
DIABETES CARE UPDATES: FROM DIAGNOSIS TO CRISIS MANAGEMENT
Are We Failing DKA Patients with Outdated Care?
What to do if Diabetes Type is Unclear , and Why Does It Matter?
Discover Effective Diabetes Care in Just 1 Minute!
02
03
04
06
07
08
09
DIABETES AND ITS PARTNERS: MANAGING HEART & KIDNEY HEALTH
CKD Screening and Maintenance: The Latest Guidelines
Cardiovascular Risk and Type 2 Diabetes: What’s New?
12
MENTAL HEALTH MATTERS IN DIABETES CARE
7 Critical Psychosocial Concerns in Diabetes Care You Must Know!
How do Mental Health and Obesity Intersect?
15
AI IN DIABETES: THE FUTURE OF SMARTER CARE
AI in Diabetes Primary Care Delivery
10
11
13
14
16
09
GLP-1 AGONISTS:
Transforming Diabetes and Obesity Care
2
MediBrief | February 2025
GLP-1 AGONISTS: TRANSFORMING DIABETES AND OBESITY CARE
Why Are GLP-1 Receptor Agonists A Game-changer for Type 2 Diabetes?
Dr. Joshua Neumiller explains their benefits, including kidney protection, cardiovascular benefits, and emerging indications for conditions like sleep apnea and Alzheimer's.
MediBrief I.M & ENDOCRINE
3
MediBrief | February 2025
GLP-1 AGONISTS: TRANSFORMING DIABETES AND OBESITY CARE
MediBrief I.M & ENDOCRINE
Are GLP-1 Receptor Agonists A Breakthrough for Weight Loss or A Muscle Mass Disaster?
Dr. Zhenqi Liu explores the e fects on fat and muscle, o fering on resistance training and protein intake. INSIGHTS
4
MediBrief | February 2025
GLP-1 AGONISTS: TRANSFORMING DIABETES AND OBESITY CARE
What’s New in Obesity Management?
MediBrief I.M & ENDOCRINE
BMI-focused care Is obesity treatment evolving? Dr. Samar Hafida explores FDA-approved medications, new therapies, and the shi t from to comprehensive approaches for improving health in obesity and related conditions.
DIABETES CARE UPDATES: From Diagnosis to Crisis Management
6
MediBrief | February 2025
DIABETES CARE UPDATES: FROM DIAGNOSIS TO CRISIS MANAGEMENT
Dr. Rodolfo Galindo reveals 2024's game-changing updates in diagnosis, management, and discharge planning. Are we Failing DKA Patients with Outdated Care?
Discover how to prevent dangerous recurrences today!
MediBrief I.M & ENDOCRINE
7
MediBrief | February 2025
DIABETES CARE UPDATES: FROM DIAGNOSIS TO CRISIS MANAGEMENT
MediBrief I.M & ENDOCRINE
What to do if Diabetes Type is Unclear, and Why Does It Matter?
Dr. Rozalina McCoy exposes the hidden threat of shares 2024 diagnosis updates, and spotlights Teplizumab's promise. Discover the future of accurate, personalized diabetes care today! LADA
8
MediBrief | February 2025
DIABETES CARE UPDATES: FROM DIAGNOSIS TO CRISIS MANAGEMENT
Discover Effective Diabetes Care in Just 1 Minute!
MediBrief I.M & ENDOCRINE
ADA RESOURCES Professor Juan Pesqueira shares how a team-based approach, DSMES , and new can improve patient outcomes and quality of life.
DIABETES AND ITS PARTNERS
Managing Heart & Kidney Health
10
MediBrief | February 2025
DIABETES AND ITS PARTNERS: MANAGING HEART & KIDNEY HEALTH
MediBrief I.M & ENDOCRINE
CKD Screening and Maintenance: The Latest Guidelines
CKD kills before dialysis begins. Dr. Sylvia Rosas shares on screening, treatment pillars, key trials, and future strategies. Stay ahead— save kidneys, save lives with early action! 2025 updates
11
MediBrief | February 2025
DIABETES AND ITS PARTNERS: MANAGING HEART & KIDNEY HEALTH
Cardiovascular Risk and Type 2 Diabetes: What’s new? Dr. John Anderson discusses recent trials, including semaglutide, tirzepatide, and AI innovations, of heart disease prevention and treatment. SHAPING THE FUTURE
MediBrief I.M & ENDOCRINE
MENTAL HEALTH MATTERS IN DIABETES CARE
13
MediBrief | February 2025
MENTAL HEALTH MATTERS IN DIABETES CARE
7 Critical Psychosocial Concerns in Diabetes Care You Must Know!
MediBrief I.M & ENDOCRINE
Dr. Liz Beverly shares essential updates on managing distress, anxiety, depression, disordered eating, and more, plus strategies to improve patient well-being!
14
MediBrief | February 2025
MENTAL HEALTH MATTERS IN DIABETES CARE
How do Mental Health and Obesity Intersect? Dr. Kimberly Gudzune discusses the link between obesity, depression, and anxiety and highlights e fective treatments and strategies for better patient outcomes and care.
MediBrief I.M & ENDOCRINE
AI IN DIABETES
The Future of Smarter Care
16
MediBrief | February 2025
AI IN DIABETES: THE FUTURE OF SMARTER CARE
MediBrief I.M & ENDOCRINE
AI in Diabetes Primary Care Delivery
REVOLUTIONIZING CARE DELIVERY How is AI transforming diabetes care? Dr. David Kerr explores AI's role in retinal screening, kidney disease detection, and continuous glucose monitoring, with real-time data and personalized treatment.
MEET THE TEAM
EDITORIAL TEAM
EDITOR IN CHIEF AHMED HEGAZY
THIS IS THE FIRST ISSUE OF MEDIBRIEF INTERNAL MEDICINE
EDITOR CLARA NAGY
MAGAZINE DESIGNER MARIAM GOMAA CONTENT CREATOR MARINA REFAAT
EXPECT OUR PUBLICATION EVERY OF THE MONTH 15TH DAY
MediBrief I.M & ENDOCRINE
ABOUT US?
OUR MISSION
To democratize medical updates for all healthcare professionals.
WE DELIVER...
Concise, easy-to-digest videos , presenting updates from the most credible conferences and journals , right to your fingertips . Our bite-sizesd updates keep you informed without eating into your valuable time, so you can focus on what matters most: Delivering Exceptional Patient Care.
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23Made with FlippingBook - professional solution for displaying marketing and sales documents online